These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2713883

  • 1. [Accumulation of aluminum in the dialyzed patient: incidence, causes and possibilities of prevention].
    Sulková S, Laurincová Z, Lapcík O, Dlhopolcek P, Stodolová E, Komonová D.
    Cas Lek Cesk; 1989 Jan 02; 128(1):16-9. PubMed ID: 2713883
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
    Sulková S, Laurincová Z, Pancírová J, Komonová D, Válek A.
    Cas Lek Cesk; 1990 Aug 10; 129(32):998-1001. PubMed ID: 2208242
    [Abstract] [Full Text] [Related]

  • 3. [Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
    Günther K, Winnefeld K, Stein G, Sperschneider H, Schröter H, Fünfstück R.
    Z Urol Nephrol; 1986 Oct 10; 79(10):569-76. PubMed ID: 3811645
    [Abstract] [Full Text] [Related]

  • 4. [Elimination of aluminum via continuous ambulatory peritoneal dialysis].
    Passlick J, Wilhelm M, Busch T, Grabensee B, Ohnesorge FK.
    Dtsch Med Wochenschr; 1989 Jan 06; 114(1):9-13. PubMed ID: 2910699
    [Abstract] [Full Text] [Related]

  • 5. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

  • 6. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F, Monnier N, Reveillaud RJ.
    Proc Eur Dial Transplant Assoc; 1983 Dec 15; 20():207-12. PubMed ID: 6657657
    [Abstract] [Full Text] [Related]

  • 7. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF, D'Haese PC, Lamberts LV, Djukanovic L, Pejanovic S, Goodman WG, De Broe ME.
    Clin Nephrol; 1998 Aug 15; 50(2):69-76. PubMed ID: 9725776
    [Abstract] [Full Text] [Related]

  • 8. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H, Stummvoll HK, Kovarik J, Meisinger V, Wolf A, Pinggera WF.
    Wien Klin Wochenschr; 1980 Aug 15; 92(11):391-4. PubMed ID: 7424016
    [Abstract] [Full Text] [Related]

  • 9. Prevention and treatment of aluminum overload in uremic patients: long-term results.
    Canavese C, Thea A, Pacitti A, Salomone M, Mangiarotti G, Segoloni G, Stratta P, Gurioli L, Constantini S, Giordini R.
    Clin Nephrol; 1989 Apr 15; 31(4):169-74. PubMed ID: 2714022
    [Abstract] [Full Text] [Related]

  • 10. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P, Olsen F, Heaf JG, Gammelgaard B, Pödenphant J.
    Clin Nephrol; 1989 Sep 15; 32(3):133-8. PubMed ID: 2791364
    [Abstract] [Full Text] [Related]

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 12. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 13. The influence of aluminium on parathyroid hormone levels in haemodialysis patients.
    Cannata JB, Briggs JD, Junor BJ, Beastall G, Fell GS.
    Proc Eur Dial Transplant Assoc; 1983 Jun 14; 19():244-7. PubMed ID: 6878239
    [Abstract] [Full Text] [Related]

  • 14. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
    Wallace MR, Pybus J.
    N Z Med J; 1983 Oct 26; 96(742):793-5. PubMed ID: 6578451
    [Abstract] [Full Text] [Related]

  • 15. Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids.
    Rovelli E, Luciani L, Pagani C, Albonico C, Colleoni N, D'Amico G.
    Clin Nephrol; 1988 Jun 26; 29(6):294-8. PubMed ID: 3396232
    [Abstract] [Full Text] [Related]

  • 16. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW, Stewart Wk, Fell GS, Halls DJ.
    Clin Nephrol; 1982 May 26; 17(5):222-7. PubMed ID: 7094439
    [Abstract] [Full Text] [Related]

  • 17. Role of medication in the level of aluminium in the blood of chronic haemodialysis patients.
    Bohrer D, Bertagnolli DC, de Oliveira SM, do Nascimento PC, de Carvalho LM, Garcia SC, Arantes LC, Barros EJ.
    Nephrol Dial Transplant; 2009 Apr 26; 24(4):1277-81. PubMed ID: 19028749
    [Abstract] [Full Text] [Related]

  • 18. [Aluminum osteopathy--experience with therapy].
    Sulková S.
    Vnitr Lek; 1993 May 26; 39(5):459-63. PubMed ID: 8351877
    [Abstract] [Full Text] [Related]

  • 19. Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism.
    Moriniere P, Roussel A, Tahiri Y, de Fremont JF, Maurel G, Jaudon MC, Gueris J, Fournier A.
    Proc Eur Dial Transplant Assoc; 1983 May 26; 19():784-7. PubMed ID: 6878265
    [Abstract] [Full Text] [Related]

  • 20. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM, Allen KR, Newton KE.
    Ann Clin Biochem; 2005 Jan 26; 42(Pt 1):51-4. PubMed ID: 15802033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.